Clinical Efficiency and Prognosis of Milrinone Plus Metoprolol to Patients with Intractable Heart Failure

Qi ZHANG,Li-qun HU
DOI: https://doi.org/10.3969/j.issn.2095-1434.2011.11.001
2011-01-01
Abstract:Objective:To analyze the clinical efficiency and prognosis of milrinone plus metoprolol to patients with intractable heart failure.Methods:A total of 76 patients in hospital with heart function 3~4 class,rational clinical administration and correction heart failure inducement were divided into two groups,research group(be given conventional therapy,37 cases) and control group(be given conventional therapy and administration of milrinone plus metoprolol,39 cases),according to the therapeutic schedule.The course of the treatments were all one month.The six-minute walk test and Ultrasonic Cardiogram were been performed to all patients.The indexs of heart function were been compared between two groups.After one year follow-up,the indexs of prognosis,such as readmission rate and sudden death rate,were been compared between two groups.Results:Compared to control group,the distance of six-minute walk test,heart rate,LVEF,LVd and stroke volume in research group were better(P0.05),and the readmission rate and sudden death rate in research group were lower(P0.05).Conclusions:The clinical efficiency of milrinone plus metoprolol to patients with intractable heart failure was more marked,and prognosis was better.
What problem does this paper attempt to address?